| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,752 |
5,757 |
$279K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
6,858 |
1,537 |
$206K |
| 99223 |
Prolong inpt eval add15 m |
2,232 |
2,016 |
$127K |
| 99233 |
Prolong inpt eval add15 m |
3,327 |
1,671 |
$113K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,343 |
2,903 |
$103K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,712 |
1,603 |
$44K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,210 |
1,116 |
$42K |
| 93000 |
|
2,365 |
2,238 |
$27K |
| 99401 |
|
1,450 |
1,302 |
$26K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
267 |
259 |
$15K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,779 |
1,628 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,675 |
1,492 |
$9K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
158 |
155 |
$8K |
| 99442 |
|
529 |
431 |
$8K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,984 |
1,834 |
$7K |
| 99490 |
Ccm add 20min |
4,939 |
4,173 |
$4K |
| 90674 |
|
91 |
87 |
$2K |
| 99354 |
|
38 |
38 |
$2K |
| 81002 |
|
2,250 |
2,110 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,308 |
1,126 |
$1K |
| 99252 |
|
14 |
13 |
$756.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
70 |
65 |
$645.81 |
| 99222 |
Initial hospital care, per day, moderate complexity |
12 |
12 |
$577.72 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
20 |
$490.95 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19 |
14 |
$461.97 |
| 99441 |
|
42 |
39 |
$389.10 |
| G0008 |
Administration of influenza virus vaccine |
60 |
58 |
$366.20 |
| 90756 |
|
12 |
12 |
$195.36 |
| 99439 |
|
184 |
162 |
$195.10 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
171 |
110 |
$156.44 |
| 90661 |
|
15 |
14 |
$127.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
14 |
13 |
$91.31 |
| 99406 |
|
13 |
12 |
$83.45 |
| 3008F |
|
7,009 |
5,911 |
$40.00 |
| 94760 |
|
51 |
48 |
$1.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
1,251 |
977 |
$0.00 |
| 1036F |
|
1,980 |
1,825 |
$0.00 |
| 3075F |
|
436 |
384 |
$0.00 |
| 3074F |
|
2,058 |
1,568 |
$0.00 |
| 3080F |
|
232 |
206 |
$0.00 |
| 3079F |
|
859 |
773 |
$0.00 |
| 3044F |
|
578 |
511 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
76 |
58 |
$0.00 |
| 3014F |
|
13 |
12 |
$0.00 |
| 3078F |
|
1,538 |
1,232 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
5,549 |
4,667 |
$0.00 |
| 99072 |
|
415 |
382 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
1,196 |
924 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
112 |
96 |
$0.00 |
| 4004F |
|
63 |
60 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
47 |
40 |
$0.00 |
| 3077F |
|
49 |
39 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
21 |
18 |
$0.00 |